Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000724277 | SCV000209429 | benign | not provided | 2020-10-19 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000724277 | SCV000232733 | uncertain significance | not provided | 2014-12-19 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000515226 | SCV000611536 | uncertain significance | Mowat-Wilson syndrome | 2017-05-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000515226 | SCV000763927 | benign | Mowat-Wilson syndrome | 2023-12-28 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000515226 | SCV002045594 | likely benign | Mowat-Wilson syndrome | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001818349 | SCV002072026 | uncertain significance | not specified | 2017-09-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002415697 | SCV002727105 | likely benign | Inborn genetic diseases | 2017-12-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000724277 | SCV004033762 | likely benign | not provided | 2023-07-01 | criteria provided, single submitter | clinical testing | ZEB2: BS2 |